The FCM was performed as previously reported (10). Peritoneal exudates and cultured PMNs and MΦs were used for determining indicated antigens, including CD11b (clone M1/70, catalog no. 101206, BioLegend, San Diego, CA), F4/80 (clone BM8, catalog nos. 123110 and 123116, BioLegend), Ly6G (clone 1A8, catalog no. 127618, BioLegend), annexin V (catalog no. 640930, BioLegend), and mFgl2 (clone 6D9). The cellular fluorescence was assessed using FACSCanto II (BD), and data were analyzed with FlowJo v10 (Tree Star Inc., Ashland, OR). In Treg experiments, spleen CD4+CD25+ Tregs were isolated by fluorescence-activated cell sorting (FACS) and then treated with or without RvDp5 (10 nM) for 24 hours.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.